Coryx (Tablets) 53 mg Effervescent tablets

Coryx (Tablets) 53 mg Effervescent tablets

S2
PDF Leaflet Revision Date: 26 January 2022


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of symptoms associated with colds and influenza in adults and children over 16 years.

Dosage (summary)

One tablet every 8 hours as needed for adults and children over 16.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • MAOIs
  • CNS depressants
  • NSAIDs

Contraindications

  • Children under 16 years
  • Hypersensitivity to ingredients
  • Coronary disease
  • Hypertension
  • Gastrointestinal bleeding
  • Pregnancy
  • Breastfeeding

Common side effects

  • Drowsiness
  • Gastrointestinal disturbances
  • Tachycardia

Counselling Points

  • Avoid alcohol
  • Do not exceed 10 days of use without consulting a doctor
  • May cause drowsiness

Serious warnings

  • Risk of gastrointestinal bleeding
  • Cardiovascular events
  • Serious skin reactions
Important Disclaimer

The Coryx (Tablets) 53 mg Effervescent tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites